chlorpropamide and Diaphragmatic Hernia studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Research Excerpts

Excerpt	Relevance	Reference
") was used to diagnose chemical diabetes during pregnancy in 180 women, 50 of whom subsequently received chlorpropamide therapy in a daily dosage of 100 mg; the remainder had no drug therapy."	7.65	Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. ( Bewsher, PD; Cormack, JD; Stowers, JM; Sutherland, HW, 1973)
") was used to diagnose chemical diabetes during pregnancy in 180 women, 50 of whom subsequently received chlorpropamide therapy in a daily dosage of 100 mg; the remainder had no drug therapy."	3.65	Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. ( Bewsher, PD; Cormack, JD; Stowers, JM; Sutherland, HW, 1973)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

chlorpropamide and Diaphragmatic Hernia

Research Excerpts

Research

Studies (1)

Authors

Other Studies